RFK Jr. to speed up development and availability of low-cost alternatives to the costliest drugs

RFK Jr. to speed up development and availability of low-cost alternatives to the costliest drugs




The Trump administration moved Wednesday to accelerate the development and availability of a broad class of low-cost, competitive drugs that promise to cut billions of dollars in U.S. spending on pharmaceuticals for diabetes, cancer and other conditions.



Source link

Posted in

Swedan Margen

I focus on highlighting the latest in business and entrepreneurship. I enjoy bringing fresh perspectives to the table and sharing stories that inspire growth and innovation.

Leave a Comment